Have Complications Related to Balloon Pulmonary Angioplasty Changed Since its Inception?

Balloon pulmonary angioplasty: Evolution over time and its complications


Balloon pulmonary angioplasty (BPA) has grown from its beginnings as an indication for patients with chronic thromboembolic pulmonary hypertension (CTEPH) to being currently a class 1 indication for inoperable patients and/or residual CTEPH. Current evidence on this topic is underpowered, as most reports are based on a small number of patients.

¿Han cambiado las complicaciones relacionadas a la angioplastia pulmonar con balón desde sus inicios? 

Researchers conducted a systematic review on papers reporting on BPA and its results. In addition, the rate of complications related to BPA was analyzed for two time periods, 2013-2017 and 2018-2022. 

The primary endpoint (PEP) was the incidence of BPA-related complications, defined as vessel injury or hemoptysis, use of mechanical ventilation, or procedure-related death.

The analysis included a total of 1714 CTEPH patients, who accounted for a total of 7561 BPA sessions. The mean follow-up was 7.3 months after the procedure. Results showed that the incidence of hemoptysis or vessel injury was 11.1%, the rate of reperfusion edema was 6%, the rate of mechanical ventilation was 0.4%, and the mortality rate was 1.3%.

Read also: AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography.

When complications were analyzed over the two time periods, the cumulative incidence of hemoptysis and vessel injury decreased from 14.1% to 7.7% (p < 0.01), reperfusion edema decreased from 11.3% to 1.4% (p < 0.01), mechanical ventilation decreased from 0.7% to 0.1% (p < 0.01), and even mortality decreased from 2% to 0.8% (p < 0.01).

Conclusion

BPA is running its natural course, becoming a safe procedure as time goes by. Further research is needed to improve procedural technique, patient selection, and treated lesion characteristics.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Periprocedural Complications With Balloon Pulmonary Angioplasty Analysis of Global Studies 

Reference: Nishant Jain, MD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...